Use of national linked healthcare, serology and viral genomic data to identify and characterise post-third and -booster dose vaccine breakthroughs at a population level

Project Details

StatusFinished
Effective start/end date1/04/21 → 30/09/22

Funding

  • Other: £3,291.00
  • Other: £270,557.00
  • Other: £18,512.00
  • Other: £34,966.00